Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motif
- 1 January 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (7) , 887-892
- https://doi.org/10.1016/s0960-894x(01)80257-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993
- PROTEIN PRENYLATION: GENES, ENZYMES, TARGETS, AND FUNCTIONSAnnual Review of Genetics, 1992
- Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.Proceedings of the National Academy of Sciences, 1992
- Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity.Proceedings of the National Academy of Sciences, 1992
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990
- p21ras is modified by a farnesyl isoprenoid.Proceedings of the National Academy of Sciences, 1989
- Structure of conformationally constrained peptides: From model compounds to bioactive peptidesBiopolymers, 1989
- Cyanohydridoborate anion as a selective reducing agentJournal of the American Chemical Society, 1971
- An Improved Wolff Rearrangement in Homogeneous Medium1Journal of the American Chemical Society, 1950